CDKN2A-positive breast cancers in young women from Poland
- 24 October 2006
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 103 (3) , 355-359
- https://doi.org/10.1007/s10549-006-9382-x
Abstract
Purpose: To investigate the contribution of CDKN2A A148T common variant to early-onset breast cancer in Poland, and to establish the characteristic features of these cancers. Experimental design: We studied 3,069 women diagnosed with breast cancer under the age of 51 and 3,493 population controls. CDKN2A variant were detected using RFLP-PCR and confirmed by genomic sequencing. Clinical and pathological features of CDKN2A-positive cases and CDKN2A-negative cases were compared. Results: A148T variant was identified in 157 of 3,069 women with breast cancer (5.1%). Overall, the odds ratio for early-onset breast cancer, given a CDKN2A variant was 1.4 (95% CI 1.075–1.725; P = 0.012). Breast tumors in women with the CDKN2A variant were more commonly intraductal cancers (DCIS) with micro-invasion (14.8% vs. 8.5%; P = 0.035). Carriers and non-carriers were similar with respect to tumor size, laterality, multicentricity, nodal status, family history and estrogen-receptor status. Conclusion: The CDKN2A A148T variant seems to contribute to early-onset breast cancer in Poland. Breast tumors which arise in carriers of A148T variant appear to be similar to those of breast cancers in the population at large.Keywords
This publication has 22 references indexed in Scilit:
- Histopathology of BRCA1- and BRCA2-associated breast cancerCritical Reviews in Oncology/Hematology, 2006
- The A148T Variant of the CDKN2A Gene Is Not Associated with Melanoma Risk in the French and Italian PopulationsJournal of Investigative Dermatology, 2006
- BRCA1-positive breast cancers in young women from PolandBreast Cancer Research and Treatment, 2006
- The 3020insC allele of NOD2 predisposes to early-onset breast cancerBreast Cancer Research and Treatment, 2005
- Germline mutation and large deletion analysis of theCDKN2A andARF genes in families with multiple melanoma or an aggregation of malignant melanoma and breast cancerInternational Journal of Cancer, 2004
- Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast CancerJNCI Journal of the National Cancer Institute, 2003
- An Assessment of the CDKN2A Variant Ala148Thr as a Nevus/Melanoma Susceptibility AlleleJournal of Investigative Dermatology, 2002
- Methylation of the p16Ink4a tumor suppressor gene 5′-CpG island in breast cancerCancer Letters, 2001
- In-situ breast cancer and BRCA 1The Lancet, 1996
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993